NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by β-amyloid protein in rats

被引:27
作者
Tanaka, T
Yamada, K
Senzaki, K
Narimatsu, H
Nishimura, K
Kameyama, T
Nabeshima, T [1 ]
机构
[1] Nagoya Univ, Sch Med, Dept Neuropsychopharmcol & Hosp Pharm, Showa Ku, Nagoya, Aichi 4668560, Japan
[2] Meijo Univ, Fac Pharmaceut Sci, Dept Chem Pharmacol, Tenpaku Ku, Nagoya, Aichi 4680077, Japan
关键词
arginine vasopressin; Alzheimer's disease; beta-amyloid protein; choline acetyltransferase; learning; memory; NC-1900;
D O I
10.1016/S0014-2999(98)00344-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have reported that the continuous infusion of beta-amyloid protein-(1-40) into the rat cerebral ventricle produces learning and memory deficits accompanied by dysfunction in the cholinergic and dopaminergic systems. L-Pyroglutamyl-L-asparaginyl-r-seryl-L-prolyl-L-arginylglycinamide (NC-1900), an active fragment analog of arginine vasopressin in the rat brain, is a stable peptide with a five-fold longer half-life than that of arginine vasopressin-(4-9). In the present study, we examined the effects of NC-1900 on learning and memory deficits in beta-amyloid protein-(1-40)-infused rats. The rats were injected subcutaneously with NC-1900 (0.1 and 1 ng kg(-1)) once a day throughout the period of behavioral examination. In the beta-amyloid protein-infused rats, learning and memory in water maze and passive avoidance tasks were impaired compared with these in the control rats. NC-1900 prevented the learning and memory deficits in beta-amyloid protein-infused rats. Moreover, NC-1900 tended to increase the choline acetyltransferase activity in the frontal cortex of the beta-amyloid protein-infused rats. These results suggested that NC-1900 could be useful for the treatment of patients with Alzheimer's disease. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 37 条
[1]   HIPPOCAMPAL-LESIONS BLOCK BEHAVIORAL-EFFECTS OF CENTRAL BUT NOT OF PERIPHERAL PRETEST INJECTION OF ARGININE VASOPRESSIN IN AN APPETITIVE LEARNING-TASK [J].
ALESCIOLAUTIER, B ;
DEVIGNE, C ;
SOUMIREUMOURAT, B .
BEHAVIOURAL BRAIN RESEARCH, 1987, 26 (2-3) :159-169
[2]   EFFECTS OF VASOPRESSIN ON ACTIVE AND PASSIVE AVOIDANCE BEHAVIOR [J].
BOHUS, B ;
ADER, R ;
WIED, DD .
HORMONES AND BEHAVIOR, 1972, 3 (03) :191-&
[3]   A MAJOR METABOLITE OF ARGININE VASOPRESSIN IN THE BRAIN IS A HIGHLY POTENT NEUROPEPTIDE [J].
BURBACH, JPH ;
KOVACS, GL ;
DEWIED, D ;
VANNISPEN, JW ;
GREVEN, HM .
SCIENCE, 1983, 221 (4617) :1310-1312
[4]   ALZHEIMERS-DISEASE - A DISORDER OF CORTICAL CHOLINERGIC INNERVATION [J].
COYLE, JT ;
PRICE, DL ;
DELONG, MR .
SCIENCE, 1983, 219 (4589) :1184-1190
[5]  
DEWIED D, 1987, J PHARMACOL EXP THER, V241, P268
[6]   CENTRAL TARGET FOR THE BEHAVIORAL-EFFECTS OF VASOPRESSIN NEUROPEPTIDES [J].
DEWIED, D ;
GAFFORI, O ;
VANREE, JM ;
DEJONG, W .
NATURE, 1984, 308 (5956) :276-278
[7]  
DEWIED D, 1979, FED PROC, V38, P2348
[8]   Vasopressin and memory .2. Lesions to the hippocampus block the memory enhancing effects of AVP(4-9) in the radial maze [J].
Dietrich, A ;
Allen, JD .
BEHAVIOURAL BRAIN RESEARCH, 1997, 87 (02) :201-208
[9]   Effect of active fragments of arginine-vasopressin on the disturbance of spatial cognition in rats [J].
Fujiwara, M ;
Ohgami, Y ;
Inada, K ;
Iwasaki, K .
BEHAVIOURAL BRAIN RESEARCH, 1997, 83 (1-2) :91-96
[10]   No 302, a newly synthesized [pGlu(4),Cyt(6)]AVP(4-9) analogue, prevents the disruption of avoidance behavior [J].
Hirate, K ;
Hirano, M ;
Nakajima, Y ;
Hiyama, A ;
Maeda, O ;
Asakura, W .
BEHAVIOURAL BRAIN RESEARCH, 1997, 83 (1-2) :205-208